title: DBS in Dystonia and Other Hyperkinetic Movement Disorders.
abstract: The diagnosis and appropriate treatment of hyperkinetic movement disorders require a work up of potentially reversible metabolic, infectious and structural disorders as well as side effects of current medication. In pharmacoresistant movement disorders with a disabling impact on quality of life, deep brain stimulation (DBS) should be considered. At different targets, DBS has become an established therapy for Parkinson's disease (GPi-STN), tremor (VIM) and primary dystonia (GPi) with reasonable perioperative risks and side effects, established guidelines and some clinical and radiological predictive factors. In contrast, for other hyperkinetic movement disorders, including secondary dystonia, Gilles de la Tourette, chorea and ballism, only few data are available. Definite targets are not well defined, and reported results are of less magnitude than those of the recognized indications. In this expanding therapeutical field without worked out recommendations, an individual approach is needed with DBS indication assessment only after rigorous multidisciplinary scrutiny, restricted to expert centres.
authors.affiliation: Department of Neurology, Centre Hospitalier Universitaire Vaudois (CHUV), Rue de Bugnon 21, CH-1011, Lausanne, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Barbey
authors.forename: J
authors.initials: J
authors.lastname: Bloch
authors.forename: F J G
authors.initials: FJ
authors.lastname: Vingerhoets